Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H U Bryant

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Journal of Neuroendocrinology|January 23, 2008
The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemiaT D Farr, H V O Carswell, D J McCann, et al.
Journal of Medicinal Chemistry|August 10, 2001
Photochemical synthesis of N-arylbenzophenanthridine selective estrogen receptor modulators (serms)T A Grese, M D Adrian, D L Phillips, et al.
Brain Research|November 24, 1999
Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized ratsX Wu, M A Glinn, N L Ostrowski, et al.
AIDS Research and Human Retroviruses|April 1, 1992
No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytesE W Bernton, H U Bryant, M A Decoster, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized ratsN Bowling, W E Bloomquist, M L Cohen, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 8, 2000
The effect of raloxifene on coronary arteries in aged ovariectomized ewesJ S Gaynor, E Monnet, C Selzman, et al.
Molecular Pharmacology|November 24, 2004
The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonistV Krishnan, H A Bullock, B C Yaden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized ratsM Sato, H U Bryant, P Iversen, et al.
Cancer Research|December 4, 2001
Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancerN Suh, A L Glasebrook, A D Palkowitz, et al.
Life Sciences|January 1, 1996
A novel class of 5-HT2A receptor antagonists: aryl aminoguanidinesH U Bryant, D L Nelson, D Button, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Journal of Neuroendocrinology|January 23, 2008
The selective oestrogen receptor modulator, LY362321, is not neuroprotective in a rat model of transient focal ischaemiaT D Farr, H V O Carswell, D J McCann, et al.
Journal of Medicinal Chemistry|August 10, 2001
Photochemical synthesis of N-arylbenzophenanthridine selective estrogen receptor modulators (serms)T A Grese, M D Adrian, D L Phillips, et al.
Brain Research|November 24, 1999
Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized ratsX Wu, M A Glinn, N L Ostrowski, et al.
AIDS Research and Human Retroviruses|April 1, 1992
No direct neuronotoxicity by HIV-1 virions or culture fluids from HIV-1-infected T cells or monocytesE W Bernton, H U Bryant, M A Decoster, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Effects of prolonged ethinyl estradiol treatment on calcium channel binding and in vivo calcium-mediated hemodynamic responses in ovariectomized ratsN Bowling, W E Bloomquist, M L Cohen, et al.
Journal of Veterinary Pharmacology and Therapeutics|December 8, 2000
The effect of raloxifene on coronary arteries in aged ovariectomized ewesJ S Gaynor, E Monnet, C Selzman, et al.
Molecular Pharmacology|November 24, 2004
The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonistV Krishnan, H A Bullock, B C Yaden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1996
Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized ratsM Sato, H U Bryant, P Iversen, et al.
Cancer Research|December 4, 2001
Arzoxifene, a new selective estrogen receptor modulator for chemoprevention of experimental breast cancerN Suh, A L Glasebrook, A D Palkowitz, et al.
Life Sciences|January 1, 1996
A novel class of 5-HT2A receptor antagonists: aryl aminoguanidinesH U Bryant, D L Nelson, D Button, et al.
Pageof 7